Background: Unlike other neuroendocrine tumors of the gastrointestinal tract, management of duodenal and periampullary carcinoids remains controversial. We aimed to determine the metastatic potential and optimal choice of therapy for these neoplasms.
Methods: A retrospective review of all patients treated at the Johns Hopkins Hospital between 1996 and 2012 was conducted.